IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-021-27761-z.html
   My bibliography  Save this article

Population homogeneity for the antibody response to COVID-19 BNT162b2/Comirnaty vaccine is only reached after the second dose across all adult age ranges

Author

Listed:
  • João Faro-Viana

    (CHLO, Centro Hospitalar de Lisboa Ocidental, Serviço de Patologia Clínica)

  • Marie-Louise Bergman

    (IGC, Instituto Gulbenkian de Ciência)

  • Lígia A. Gonçalves

    (IGC, Instituto Gulbenkian de Ciência)

  • Nádia Duarte

    (IGC, Instituto Gulbenkian de Ciência)

  • Teresa P. Coutinho

    (University of Lisbon)

  • Patrícia C. Borges

    (IGC, Instituto Gulbenkian de Ciência)

  • Christian Diwo

    (IGC, Instituto Gulbenkian de Ciência)

  • Rute Castro

    (IBET, Instituto de Biologia Experimental e Tecnológica)

  • Paula Matoso

    (IGC, Instituto Gulbenkian de Ciência)

  • Vanessa Malheiro

    (IGC, Instituto Gulbenkian de Ciência)

  • Ana Brennand

    (IGC, Instituto Gulbenkian de Ciência)

  • Lindsay Kosack

    (IGC, Instituto Gulbenkian de Ciência)

  • Onome Akpogheneta

    (IGC, Instituto Gulbenkian de Ciência)

  • João M. Figueira

    (CHLO, Centro Hospitalar de Lisboa Ocidental, Serviço de Patologia Clínica)

  • Conceição Cardoso

    (CHLO, Centro Hospitalar de Lisboa Ocidental, Serviço de Patologia Clínica)

  • Ana M. Casaca

    (CHLO, Centro Hospitalar de Lisboa Ocidental, Serviço de Patologia Clínica)

  • Paula M. Alves

    (IBET, Instituto de Biologia Experimental e Tecnológica
    Universidade Nova de Lisboa)

  • Telmo Nunes

    (University of Lisbon)

  • Carlos Penha-Gonçalves

    (IGC, Instituto Gulbenkian de Ciência)

  • Jocelyne Demengeot

    (IGC, Instituto Gulbenkian de Ciência)

Abstract

While mRNA vaccines are administrated worldwide in an effort to contain the COVID-19 pandemic, the heterogeneity of the humoral immune response they induce at the population scale remains unclear. Here, in a prospective, longitudinal, cohort-study, including 1245 hospital care workers and 146 nursing home residents scheduled for BNT162b2 vaccination, together covering adult ages from 19 to 99 years, we analyse seroconversion to SARS-CoV-2 spike protein and amount of spike-specific IgG, IgM and IgA before vaccination, and 3-5 weeks after each dose. We show that immunogenicity after a single vaccine dose is biased to IgG, heterogeneous and reduced with increasing age. The second vaccine dose normalizes IgG seroconversion in all age strata. These findings indicate two dose mRNA vaccines is required to reach population scale humoral immunity. The results advocate for the interval between the two doses not to be extended, and for serological monitoring of elderly and immunosuppressed vaccinees.

Suggested Citation

  • João Faro-Viana & Marie-Louise Bergman & Lígia A. Gonçalves & Nádia Duarte & Teresa P. Coutinho & Patrícia C. Borges & Christian Diwo & Rute Castro & Paula Matoso & Vanessa Malheiro & Ana Brennand & L, 2022. "Population homogeneity for the antibody response to COVID-19 BNT162b2/Comirnaty vaccine is only reached after the second dose across all adult age ranges," Nature Communications, Nature, vol. 13(1), pages 1-8, December.
    • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-021-27761-z
    DOI: 10.1038/s41467-021-27761-z
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-021-27761-z
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-021-27761-z?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Elizabeth J. Williamson & Alex J. Walker & Krishnan Bhaskaran & Seb Bacon & Chris Bates & Caroline E. Morton & Helen J. Curtis & Amir Mehrkar & David Evans & Peter Inglesby & Jonathan Cockburn & Helen, 2020. "Factors associated with COVID-19-related death using OpenSAFELY," Nature, Nature, vol. 584(7821), pages 430-436, August.
    2. Zijun Wang & Fabian Schmidt & Yiska Weisblum & Frauke Muecksch & Christopher O. Barnes & Shlomo Finkin & Dennis Schaefer-Babajew & Melissa Cipolla & Christian Gaebler & Jenna A. Lieberman & Thiago Y. , 2021. "mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants," Nature, Nature, vol. 592(7855), pages 616-622, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Brandily, Paul & Brébion, Clément & Briole, Simon & Khoury, Laura, 2021. "A poorly understood disease? The impact of COVID-19 on the income gradient in mortality over the course of the pandemic," European Economic Review, Elsevier, vol. 140(C).
    2. Kuckertz, Andreas & Scheu, Maximilian, 2024. "From chalkboard to boardroom: Unveiling the role of entrepreneurship in bolstering academic achievement among professors," Journal of Business Research, Elsevier, vol. 175(C).
    3. Borau, Sylvie & Couprie, Hélène & Hopfensitz, Astrid, 2022. "The prosociality of married people: Evidence from a large multinational sample," Journal of Economic Psychology, Elsevier, vol. 92(C).
    4. Kevin J. Kramer & Erin M. Wilfong & Kelsey Voss & Sierra M. Barone & Andrea R. Shiakolas & Nagarajan Raju & Caroline E. Roe & Naveenchandra Suryadevara & Lauren M. Walker & Steven C. Wall & Ariana Pau, 2022. "Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    5. X. Tong & R. P. McNamara & M. J. Avendaño & E. F. Serrano & T. García-Salum & C. Pardo-Roa & H. L. Bertera & T. M. Chicz & J. Levican & E. Poblete & E. Salinas & A. Muñoz & A. Riquelme & G. Alter & R., 2023. "Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    6. Shelly J. Robertson & Olivia Bedard & Kristin L. McNally & Carl Shaia & Chad S. Clancy & Matthew Lewis & Rebecca M. Broeckel & Abhilash I. Chiramel & Jeffrey G. Shannon & Gail L. Sturdevant & Rebecca , 2023. "Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    7. Dorn, Florian & Lange, Berit & Braml, Martin & Gstrein, David & Nyirenda, John L.Z. & Vanella, Patrizio & Winter, Joachim & Fuest, Clemens & Krause, Gérard, 2023. "The challenge of estimating the direct and indirect effects of COVID-19 interventions – Toward an integrated economic and epidemiological approach," Economics & Human Biology, Elsevier, vol. 49(C).
    8. Denis Mongin & Nils Bürgisser & Gustavo Laurie & Guillaume Schimmel & Diem-Lan Vu & Stephane Cullati & Delphine Sophie Courvoisier, 2023. "Effect of SARS-CoV-2 prior infection and mRNA vaccination on contagiousness and susceptibility to infection," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    9. Davida S. Smyth & Monica Trujillo & Devon A. Gregory & Kristen Cheung & Anna Gao & Maddie Graham & Yue Guan & Caitlyn Guldenpfennig & Irene Hoxie & Sherin Kannoly & Nanami Kubota & Terri D. Lyddon & M, 2022. "Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater," Nature Communications, Nature, vol. 13(1), pages 1-9, December.
    10. Hiroshi Murayama & Isuzu Nakamoto & Takahiro Tabuchi, 2021. "Social Capital and COVID-19 Deaths: An Ecological Analysis in Japan," IJERPH, MDPI, vol. 18(20), pages 1-9, October.
    11. Ján Palguta & Levínský, René & Škoda, Samuel, 2021. "Do Elections Accelerate the COVID-19 Pandemic? Evidence from a Natural Experiment," GLO Discussion Paper Series 891, Global Labor Organization (GLO).
    12. Eran Mick & Alexandra Tsitsiklis & Natasha Spottiswoode & Saharai Caldera & Paula Hayakawa Serpa & Angela M. Detweiler & Norma Neff & Angela Oliveira Pisco & Lucy M. Li & Hanna Retallack & Kalani Ratn, 2022. "Upper airway gene expression shows a more robust adaptive immune response to SARS-CoV-2 in children," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    13. Luis D’Marco & María Jesús Puchades & Miguel Ángel Serra & Lorena Gandía & Sergio Romero-Alcaide & Elena Giménez-Civera & Pablo Molina & Nayara Panizo & Javier Reque & José Luis Gorriz, 2021. "SARS-CoV-2 vs. Hepatitis Virus Infection Risk in the Hemodialysis Population: What Should We Expect?," IJERPH, MDPI, vol. 18(11), pages 1-6, May.
    14. Shakhany, Mohammad Qaleh & Salimifard, Khodakaram, 2021. "Predicting the dynamical behavior of COVID-19 epidemic and the effect of control strategies," Chaos, Solitons & Fractals, Elsevier, vol. 146(C).
    15. Uchechukwu Levi Osuagwu & Chikasirimobi G Timothy & Raymond Langsi & Emmanuel K Abu & Piwuna Christopher Goson & Khathutshelo P Mashige & Bernadine Ekpenyong & Godwin O Ovenseri-Ogbomo & Chundung Asab, 2021. "Differences in Perceived Risk of Contracting SARS-CoV-2 during and after the Lockdown in Sub-Saharan African Countries," IJERPH, MDPI, vol. 18(21), pages 1-12, October.
    16. Takanao Tanaka & Shohei Okamoto, 2021. "Increase in suicide following an initial decline during the COVID-19 pandemic in Japan," Nature Human Behaviour, Nature, vol. 5(2), pages 229-238, February.
    17. Ma’ayan Israeli & Yaara Finkel & Yfat Yahalom-Ronen & Nir Paran & Theodor Chitlaru & Ofir Israeli & Inbar Cohen-Gihon & Moshe Aftalion & Reut Falach & Shahar Rotem & Uri Elia & Ital Nemet & Limor Klik, 2022. "Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    18. Andrew P. Hederman & Harini Natarajan & Leo Heyndrickx & Kevin K. Ariën & Joshua A. Wiener & Peter F. Wright & Evan M. Bloch & Aaron A. R. Tobian & Andrew D. Redd & Joel N. Blankson & Amihai Rottenstr, 2023. "SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    19. Madia, Joan E. & Moscone, Francesco & Nicodemo, Catia, 2023. "Informal care, older people, and COVID-19: Evidence from the UK," Journal of Economic Behavior & Organization, Elsevier, vol. 205(C), pages 468-488.
    20. I. Gede Nyoman M. Jaya & Henk Folmer, 2021. "Bayesian spatiotemporal forecasting and mapping of COVID‐19 risk with application to West Java Province, Indonesia," Journal of Regional Science, Wiley Blackwell, vol. 61(4), pages 849-881, September.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-021-27761-z. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.